Stock 49B BEIGENE, LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BeiGene, Ltd. Deutsche Boerse AG

Equities

49B

KYG1146Y1017

Market Closed - Deutsche Boerse AG
Other stock markets
 07:20:01 20/06/2024 BST 		Pre-market 06:40:53
10.9 EUR -0.91% Intraday chart for BeiGene, Ltd. 11.05 +1.38%
06-20 Beigene Insider Sold Shares Worth $368,162, According to a Recent SEC Filing MT
06-17 BeiGene, Ltd.(SHSE:688235) added to Shanghai Stock Exchange Health Care Sector Index CI

Chart calendar BeiGene, Ltd.

2ea5399e.B8DXhaxYTc0eDQ-oJPMB4PL-agr975K3pWtpmtOQQ8M.Xa-B1eMZK5spYzbYUoRrjLGyOGiT3Krb0iAh7ICgCLYzgpLEmCpghFF5Vg~d268221db7a35d76fe0bf2aef217cac1

Upcoming events on BeiGene, Ltd.

22/08/2024 Q2 2024 Earnings Release (Projected)
06/11/2024 Q3 2024 Earnings Release (Projected)
25/03/2025 Q4 2024 Earnings Release (Projected)
30/04/2025 Q1 2025 Earnings Release (Projected)

Past events on BeiGene, Ltd.

12/06/2024 European Hematology Association Meeting - Abstract No - P1124
12/06/2024 European Hematology Association Meeting - Abstract No - P538
12/06/2024 European Hematology Association Meeting - Abstract No - PB2546
12/06/2024 European Hematology Association Meeting - Abstract No - P698
12/06/2024 European Hematology Association Meeting - Abstract No - P562
12/06/2024 European Hematology Association Meeting - Abstract No - P697
12/06/2024 European Hematology Association Meeting - Abstract No - P898
12/06/2024 European Hematology Association Meeting - Abstract No - PB2540
12/06/2024 European Hematology Association Meeting - Abstract No - P685
12/06/2024 European Hematology Association Meeting - Abstract No - P1834
12/06/2024 European Hematology Association Meeting - Abstract No - P2045
12/06/2024 European Hematology Association Meeting - Abstract No - P1143
12/06/2024 European Hematology Association Meeting - Abstract No - P1836
12/06/2024 European Hematology Association Meeting - Abstract No - PB2954
12/06/2024 European Hematology Association Meeting - Abstract No - P702
12/06/2024 European Hematology Association Meeting - Abstract No - P700
12/06/2024 European Hematology Association Meeting - Abstract No - P1123
12/06/2024 European Hematology Association Meeting - Abstract No - P701
12/06/2024 European Hematology Association Meeting - Abstract No - P1139
12/06/2024 European Hematology Association Meeting - Abstract No - P1847

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		428
445
-3.82%		309
337
-8.35%		1 176
1 198
-1.84%		1 416
1 420
-0.32%		2 459
2 414
1.87%
3 239

EBITDA
Million USD		Released
Forecast
Spread 		-941
-685
-37.4%		-1 626
-1 453
-11.9%		-1 392
-1 201
-15.88%		-1 723
-1 678
-2.69%		-1 120
-1 105
-1.38%
-782

EBIT
Million USD		Released
Forecast
Spread 		-960
-752
-27.72%		-1 658
-1 525
-8.69%		-1 439
-1 239
-16.11%		-1 790
-1 751
-2.23%		-1 208
-1 161
-3.99%
-941

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-944
-740
-27.53%		-1 618
-1 480
-9.35%		-1 439
-1 253
-14.77%		-1 961
-1 853
-5.82%		-826
-903
8.51%
-846

Net income
Million USD		Released
Forecast
Spread 		-949
-750
-26.52%		-1 597
-1 467
-8.88%		-1 413
-1 223
-15.55%		-2 004
-1 832
-9.4%		-882
-911
3.23%
-859

EPS
USD		Released
Forecast
Spread 		-15,8
-14,0
-13.18%		-19,1
-17,8
-7.75%		-15,2
-10,0
-52.22%		-19,4
-15,0
-29.66%		-8,45
-8,56
1.3%
-9,02

Announcement Date02/03/2025/02/2125/02/2227/02/2326/02/24-

Quarterly results

Fiscal PeriodDecember 2021 S2 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		420
386
8.92%		307
260
17.76%		342
311
9.81%		388
377
2.7%		380
388
-2.08%		606
723
-16.13%		448
449
-0.36%		595
515
15.5%		1 043
946
10.32%		781
578
35.12%		634
638
-0.61%		752
675
11.32%
794


828


886


807


973

EBITDA
Million USD		Released
Forecast
Spread


-427
-247
-72.78%		-424
-310
-36.86%		-422
-355
-18.83%		-451
-442
-1.91%


-351
-346
-1.55%





-112
-232
51.55%		-565
-304
-86.18%		-236
-406
41.89%
-293


-327


-185


-312


-111

EBIT
Million USD		Released
Forecast
Spread


-443
-456
2.88%		-439
-397
-10.61%		-438
-391
-12.08%		-469
-472
0.67%		-907
-1 086
16.48%		-371
-373
0.58%		-319
-393
18.97%		-690
-781
11.66%		-134
-345
61.22%		-589
-364
-61.67%		-261
-376
30.56%
-279


-278


-210


-273


-134

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread


-421
-494
14.79%		-558
-446
-24.94%		-551
-377
-46.08%		-431
-457
5.77%		-982
-1 075
8.63%		-337
-374
10.01%		-367
-379
3.17%		-704
-729
3.37%		229
-365
162.87%		-351
-441
20.54%		-243
-309
21.23%
-259


-238


-226


-185


-108

Net income
Million USD		Released
Forecast
Spread 		-1 000
-925
-8.05%		-434
-519
16.3%		-571
-370
-54.36%		-558
-396
-40.84%		-445
-456
2.24%		-998
-1 105
9.67%		-348
-403
13.62%		-381
-381
0.04%		-730
-752
2.92%		215
-376
157.31%		-368
-431
14.81%		-251
-302
16.88%
-256


-235


-222


-185


-108

EPS
USD		Released
Forecast
Spread


-4,24
-5,32
20.35%		-5,56
-4,11
-35.12%		-5,39
-3,85
-40.04%		-4,29
-4,19
-2.47%


-3,34
-3,82
12.45%		-3,64
-3,53
-2.98%


2,01
-3,28
161.25%		-3,48
-4,03
13.68%		-2,41
-2,45
1.53%
-2,45


-2,25


-2,12


-1,81


-1,05

Announcement Date25/02/2205/05/2204/08/2209/11/2227/02/2327/02/2304/05/2302/08/2302/08/2309/11/2326/02/2408/05/24-----

Upcoming sector events for BeiGene, Ltd.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for BeiGene, Ltd.

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BGNE Stock
  4. 49B Stock
  5. Calendar BeiGene, Ltd.